Overview
News
Salaries
Products
People
Growth
Offices
Financials

Overview

Developing novel small molecules therapeutics modulating G-protein coupled receptor pathways to treat metabolic, inflammatory and fibrotic diseases..

News

Liminal Biosciences stock remains without fresh data in latest search window
Liminal Biosciences stock shows no newly surfaced price or earnings figures dated around September 20, 2026 in the available one-week search window. Investors must rely on previously reported fundamentals and historic trading data outside this window for
Read more
Report
Blog 1 year ago
Hello world!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Read more
Report
Press release Nasdaq 4 years ago
Liminal BioSciences Announces First Subject Dosed in Phase 1a Single Ascending Dose Clinical Trial of Fezagepras
LAVAL, QC and CAMBRIDGE, England, May 23, 2022/ PRNewswire/- Liminal BioSciences Inc., today announced that the first subject has been dosed in the Company's Phase 1 a single ascending dose randomized, open label, cross over clinical trial of fezagepras t
Read more
Report
News YahooFinance 5 years ago
Liminal BioSciences To Offload Plasma Collection and Plasma-Derived Therapeutics Business To Kedrion
Liminal BioSciences Inc (NASDAQ: LMNL) has agreed to sell its plasma collection and plasma-derived therapeutics business to Kedrion S.P.A. Under the Share Purchase Agreement, Liminal will enter into an option agreement with Kedrion for the right to acquir
Read more
Report

People

Bruce Pritchard
Executive Officer
Moira Daniels
Executive Officer
Marie Iskra
Executive Officer
Martin Leclerc
Executive Officer
Murielle Lortie
Executive Officer
Patrick Sartore
Executive Officer
John Moran
Executive Officer
Patrick Santore
Executive Officer
Kenneth Galbraith
Executive Officer, Director
Timothy Wach
Director
Eugene Siklos
Director
Alek Krstajic
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Laval Canada
HQ
200-500 est. staff

Financials

Total raised
$67.1M
Latest round
Venture - Series Unknown
Funding rounds
2
Funding rounds
Round Announced Amount
Venture - Series Unknown 2020 $30M Details
Venture - Series Unknown 2019 $37.1M Details